Carbone DP - Search Results

1

Somatic Mutation Spectrum of Non-Small-Cell Lung Cancer in African Americans: A Pooled Analysis.

Araujo LH, Lammers PE, Matthews-Smith V, Eisenberg R, Gonzalez A, Schwartz AG, Timmers C, Shilo K, Zhao W, Natarajan TG, Zhang J, Yilmaz AS, Liu T, Coombes K, Carbone DP. Araujo LH, et al. Among authors: carbone dp. J Thorac Oncol. 2015 Oct;10(10):1430-6. doi: 10.1097/JTO.0000000000000650. J Thorac Oncol. 2015. PMID: 26301800 Free PMC article.

2

Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.

Jagasia MH, Langer CJ, Johnson DH, Yunus F, Rodgers JS, Schlabach LL, Cohen AG, Shyr Y, Carbone DP, Devore RF. Jagasia MH, et al. Among authors: carbone dp. Clin Cancer Res. 2001 Jan;7(1):68-73. Clin Cancer Res. 2001. PMID: 11205920 Clinical Trial.

3

Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer.

Roberts JR, Eustis C, Devore R, Carbone D, Choy H, Johnson D. Roberts JR, et al. Ann Thorac Surg. 2001 Sep;72(3):885-8. doi: 10.1016/s0003-4975(01)02836-3. Ann Thorac Surg. 2001. PMID: 11565675

4

Constitutive activation of Notch3 inhibits terminal epithelial differentiation in lungs of transgenic mice.

Dang TP, Eichenberger S, Gonzalez A, Olson S, Carbone DP. Dang TP, et al. Among authors: carbone dp. Oncogene. 2003 Apr 3;22(13):1988-97. doi: 10.1038/sj.onc.1206230. Oncogene. 2003. PMID: 12673204

5

Proteomic patterns of tumour subsets in non-small-cell lung cancer.

Yanagisawa K, Shyr Y, Xu BJ, Massion PP, Larsen PH, White BC, Roberts JR, Edgerton M, Gonzalez A, Nadaf S, Moore JH, Caprioli RM, Carbone DP. Yanagisawa K, et al. Among authors: carbone dp. Lancet. 2003 Aug 9;362(9382):433-9. doi: 10.1016/S0140-6736(03)14068-8. Lancet. 2003. PMID: 12927430

6

A training-testing approach to the molecular classification of resected non-small cell lung cancer.

Yamagata N, Shyr Y, Yanagisawa K, Edgerton M, Dang TP, Gonzalez A, Nadaf S, Larsen P, Roberts JR, Nesbitt JC, Jensen R, Levy S, Moore JH, Minna JD, Carbone DP. Yamagata N, et al. Among authors: carbone dp. Clin Cancer Res. 2003 Oct 15;9(13):4695-704. Clin Cancer Res. 2003. PMID: 14581339

7

Molecular fingerprinting in human lung cancer.

Yanagisawa K, Xu BJ, Carbone DP, Caprioli RM. Yanagisawa K, et al. Among authors: carbone dp. Clin Lung Cancer. 2003 Sep;5(2):113-8. doi: 10.3816/CLC.2003.n.025. Clin Lung Cancer. 2003. PMID: 14596694 Review.

8

Significance of p63 amplification and overexpression in lung cancer development and prognosis.

Massion PP, Taflan PM, Jamshedur Rahman SM, Yildiz P, Shyr Y, Edgerton ME, Westfall MD, Roberts JR, Pietenpol JA, Carbone DP, Gonzalez AL. Massion PP, et al. Among authors: carbone dp. Cancer Res. 2003 Nov 1;63(21):7113-21. Cancer Res. 2003. PMID: 14612504

9

Role of p63 amplification and overexpression in lung cancer development.

Massion PP, Taflan PM, Rahman SM, Yildiz P, Shyr Y, Carbone DP, Gonzalez AL. Massion PP, et al. Among authors: carbone dp. Chest. 2004 May;125(5 Suppl):102S. Chest. 2004. PMID: 15136437 No abstract available.

10

Nuclear survivin as a biomarker for non-small-cell lung cancer.

Lu B, Gonzalez A, Massion PP, Shyr Y, Shaktour B, Carbone DP, Hallahan DE. Lu B, et al. Among authors: carbone dp. Br J Cancer. 2004 Aug 2;91(3):537-40. doi: 10.1038/sj.bjc.6602027. Br J Cancer. 2004. PMID: 15266313 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters